Selective depletion of CD8-positive leukocytes does not alter mercuric chloride induced acute renal failure in the rat

Experimental Nephrology

Volumn 5, Issue 1, 1997, Pages 69-81

  Ghielli, Manuela ^a,b   Verstrepen, Walter A ^a   Dauwe, Simonne ^a   Nouwen, Etienne J ^a   De Broe, Marc E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

acute renal failure, rats; CD8 positive leukocytes, selective depletion; mercuric chloride induced acute renal failure, regeneration

Indexed keywords

CD8 ANTIGEN; MERCURIC CHLORIDE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; BODY WEIGHT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CREATININE; DISINFECTANTS; EPITHELIUM; FEMALE; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, DISTAL; KIDNEY TUBULES, PROXIMAL; MERCURIC CHLORIDE; NECROSIS; NEPHRITIS, INTERSTITIAL; PROTEINURIA; RATS; RATS, WISTAR;

EID: 0031043301     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Brezis M, Rosen S, Epstein FH: Acute renal failure; in Brenner BM, Rector F (eds): The Kidney, ed 4. Philadelphia, Saunders, 1991, pp 993-1061.
2. Iaina A, Schwartz D: Renal tubular cellular and molecular events in acute renal failure. Nephron 1994;68:413-416.
3. Verbeke M, Van De Voorde J, Lameire N: Prevention of experimental acute tubular necrosis: Current clinical applications and perspectives. Adv Nephrol 1996;25:177-216.
4. Beck F, Thurau K, Gstraunthaler G: Patho' physiology and pathobiochemistry of acute renal failure; in Seldin DW, Giebisch G: The Kidney: Physiology and Pathophysiology, ed 2. New York, Raven Press, 1992, chap 94.
5. Toback FG: Regeneration after acute tubular necrosis. Kidney Int 1992;41:226-246.
6. Safirstein R, Price PM, Saggi SJ, Harris RC: Changes in gene expression after temporary renal ischemia. Kidney Int 1990;37:1515-1521.
7. Storch S, Saggi S, Megyesi J, Price PM, Safirstein R: Ureteral obstruction decreases renal prepro-epidermal growth factor and Tamm-Horsfall expression. Kidney Int 1994;46:1207-1215.
8. Verstrepen WA, Nouwen EJ, Yue XS, De Broe ME: Altered growth factor expression during toxic proximal tubular necrosis and regeneration. Kidney Int 1993;43:1267-1279.
9. Cuppage FE, Tate A: Repair of the nephron following injury with mercuric chloride. Am J Pathol 1967;14:58-65.
10. Schreiner GF, Harris KPG, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 1988;34:487-493.
11. Neilson EG: Pathogenesis and therapy of interstitial nephritis. Kidney Int 1989;35:1257-1270.
12. Boucher A, Droz D, Adafer E, Noël L-H: Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 1986;29:1043-1049.
13. Ghielli M, Verstrepen WA, Nouvren EJ, De Broe ME: Inflammatory cells in renal regeneration. Ren Fail 1996;18:355-375.
14. Klausner JM, Paterson IS, Goldman G, Kobzik L, Rodzen C, Lawrence R, Valeri CR, Shepro D, Hechtman HB: Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989;256:F794-F802.
15. Kelly KJ, Williams WW, Colvin RB, Bonventre JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994;91:812-816.
16. Zi Li J, Sharma R, Dileepan KN, Savi VJ: Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid. Kidney Int 1994;46:1025-1030.
17. Linas SL, Whittenburg D, Parsons PE, Repine JE: Ischemia increases neutrophil retention and worsens acute renal failure: Role of oxygen metabolites and ICAM-1. Kidney Int 1995;48: 1584-1591.
18. Bienvenu K, Granger DN: Leukocyte adhesion in ischemia/reperfusion. Blood Cells 1993;19: 279-289.
19. Wilson I, Gillinov AM, Curtis WE, DiNatale J, Burch RM, Gardner TJ, Cameron DE: Inhibition of neutrophil adherence improves post-ischemic ventricular performance of the neonatal heart. Circulation 1993;88:372-379.
20. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW: Functional inactivation of neutrophils with a Mac-1 (CD11b/ CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 1993;17:915-923.
21. Palier MS: Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 1989;113:379-386.
22. Verstrepen WA, Nouwen EJ, Zhu MQ, Ghielli M, De Broe ME: Time course of growth factor expression in mercuric chloride acute renal failure. Nephrol Dial Transplant 1995;10: 1361-1371.
23. Kunt TK: Basic principles of wound healing. J Trauma 1990;30(suppl 12):122-128.
24. Kanda S, Nomata K, Saha PK, Nishimura N, Yamada J, Kanatake H, Saito Y: Growth factor regulation of the renal cortical tubular cells by epidermal growth factor, insulin-like growth factor-1, acidic and basic fibroblast growth factor, and transforming growth factor-β in serum free culture. Cell Biol Int Rep 1989;13:687-699.
25. Reiss R, Funke AJ, Cieslinski DA, Humes HD: Transforming growth factor-alpha (TGFα) accelerates renal repair and recovery following ischemic injury to the kidney (abstract). Kidney Int 1990;37:492.
26. Knighton DR, Philips GD, Fiegel VD: Wound healing angiogenesis: Indirect stimulation by basic fibroblast growth factor. J Trauma 1990; 30(suppl 12):134-144.
27. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331:1286-1292.
28. Strutz F, Neilson EG: The role of lymphocytes in the progression of renal disease. Kidney Int 1994;45(suppl):106-110.
29. Verstrepen WA, Ghielli M, Nouwen EJ, De Broe ME: Selective depletion of CD8-positive T-lymphocytes in Wistar rats (abstract). Nephrol Dial Transplant 1994;9:921.
30. Green JR: Generation of cytotoxic T-cells in the rat mixed lymphocyte reaction is blocked by monoclonal antibody MRC OX-8. Immunology 1984;52:253-260.
31. Forbes RDC, Zheng S-X, Gomersall M, Al-Saffar M, Guttman RD: Evidence that recipient CD8+ T cell depletion does not alter development of chronic vascular rejection in a rat heart allograft model. Transplantation 1994;57: 1238-1246.
32. Cantrell DA, Robins RA, Brooks CG, Baldwin RW: Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets. Immunology 1982;45:97.
33. Hendrix PG, Hoylaerts MF, Nouwen EI, De Broe ME: Enzyme immunoassay of human placental and germ-cell alkaline phosphatase in serum. Clin Chem 1990;36:1793.
34. Ansari RA, Thakran RS, Berndt WO: The effects of mercuric chloride on transport by brush border and basolateral membrane vesicles isolated from rat kidney. Toxicol Appl Pharmacol 1990;106:145-153.
35. Passow H, Rothstein A, Clarkson TW: The general pharmacology of the heavy metals. Pharmacol Rev 1961;13:185-224.
36. Dallman MJ, Thomas ML, Green JR: MRC OX-19: A monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative responses. Eur J Immunol 1984;14:260-267.
37. Jefferies WA, Green JR, Williams AF: Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med 1985;162:177-127.
38. Nicollis MR, Aversa GG, Pearce NW, Spinelli A, Berger MF, Gurley KE, Hall BM: Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 1993;55: 458-468.
39. Damoiseaux JGMC, Döpp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD: Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994;83:140-147.
40. Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues: Comparison with flow cytometric analysis. Am J Pathol 1989;134:733-739.
41. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W: Current Protocols in immunology. New York, Wiley, 1994, p 5.3.4.
42. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
43. Brideau RJ, Carter PB, McMaster WR, Mason DW, Williams AF: Two subsets of rat T-lymphocytes defined with monoclonal antibodies. Eur J Immunol 1980;10:609.
44. Mohr U, Dungworth DL, Capen CC (eds): Pathobiology of the Aging Rat. International Life Sciences Institute, 1992, vol 1, pp 3-94.
45. Eddy AA, McCulloch L, Adams J, Liu T: Interstitial nephritis induced by protein overload proteinuria. Am J Pathol 1989;135:719-733.
46. Rovin BH, Harris KPG, Morrison A, Klahr S, Schreiner GF: Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest 1990;63: 213-220.
47. Köhler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
48. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H: Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984;312:548-551.
49. Waldmann H: Manipulation of T-cell responses with monoclonal antibodies. Annu Rev Immunol 1989;7:407-444.
50. Roitt I: Essential Immunology, ed 7. Oxford, Blackwell, 1991.
51. Chatenoud L, Bach J-F: Antigenic modulation: A major mechanism of antibody action. Immunol Today 1984;5:20-25.
52. Herbert J, Roser B: Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 1988;46(suppl):128-134.
53. Shizuru JA, Seydel KB, Flavin TF, Wu AP, Kong CC, Hoyt EG, Fujimoto N, Billingham ME, Starnes VA, Fathman CG: Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990;50:366-373.
54. Sayegh MH, Sablinski T, Tanaka K, Kut JP, Kwok CA, Tilney NL, Kupiec-Weglinski JW, Milford EL: Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. Transplantation 1991;51:296-299.
55. Shaffer D, Simpson MA, Milford EL, Gottschalk R, Kut JP, Maki T, Monaco AP: Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: Effect of depletion of T-cell subsets. Transplant Proc 1991; 23:679-681.
56. Sedgewick JD: Long-term depletion of CD8+ T cells in vivo in the rat: No observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur J Immunol 1988;18:495-502.
57. Deaton DH, Posselt AM, Naji A, Barker CF: Selective T-cell depletion of recipients in allogeneic small bowel transplantation. Transplant Proc 1991;23:283-284.
58. Kawasaki K, Yaoita A, Yamamoto T, Kihara I: Depletion of CD8-positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 1992; 41:1517-1526.
59. Kitamura A, Kitamura M, Nagasawa R, Maruyama N, Mitarai T, Takahashi T, Isoda K: Renal fibroblasts are sensitive to growth-repressing and matrix-reducing factors from activated lymphocytes. Clin Exp Immunol 1993; 91:516-520.
60. Van den Broek MF, De Heer E, Van Bruggen MCJ, De Roo G, Kleiverda K, Eulderink F, Van den Berg WB: Immunomodulation of streptococcal cell wall-induced arthritis: Identification of inflammatory cells and regulatory T-ccll subsets by mercuric chloride and in vivo CD8 depletion. Eur J Immunol 1992;22:3091-3095.
61. Bonventre JV, Kelly KJ: Adhesion molecules and acute renal failure. Adv Nephrol 1996;25: 159-176.